Lucent Diagnostics

LucentAD #pTau217 test was selected by Mount Sinai, who will be among the first in the world to deploy blood-based biomarkers (blood tests) and confirmatory tests for #AlzheimersDisease and related dementias (ADRD) to patients across primary and specialty care settings – early detection tools that have never before been offered to patients in the clinical setting – as part of the Davos Alzheimer’s Collaborative (DAC) Healthcare System Accurate Diagnosis project. #Dementia #HealthAwareness #diagnostics #bloodtest #endALZ

https://lnkd.in/eDZiZ8C2 #Dementia #HealthAwareness @alzassociation #diagnostics #bloodtest #endALZ

Visit Lucent Diagnostics to learn more about our best-in-class blood-based biomarker products. 🩸🧠 #alzheimers #pTau217 #Dementia #HealthAwareness #AlzheimersDisease #diagnostics #bloodtest #endALZ McCormick Place 2301 S Martin Luther King Drive Chicago, IL 60616

Visit Lucent Diagnostics to learn more about our best-in-class blood-based biomarker products. 🩸#alzheimers #pTau217 #Dementia #HealthAwareness #AlzheimersDisease #diagnostics #bloodtest #endALZ Sun, October 6 – Wed, October 9 9:30am – 5pm CDT Chicago IL

Visit Lucent Diagnostics at booth #1507 to learn more about our best-in-class blood-based biomarker products. #alzheimers #pTau217 #Dementia #HealthAwareness #AlzheimersDisease #diagnostics #bloodtest #endALZ Sun, October 6–Wed, October 9 9:30am–5pm CDT McCormick Place 2301 S Martin Luther King Drive Chicago, IL 60616 https://lnkd.in/gQKTTH7U

Lucent Diagnostics, a #Quanterix brand, is changing the landscape of #AlzheimersDisease by harnessing Quanterix Simoa™ p-Tau 217 technology. #pTau217 #Dementia #HealthAwareness @alzassociation #diagnostics #bloodtest #endALZ

Lucent Diagnostics, powered by Quanterix Simoa™ #technology, aims to change the landscape of #AlzheimersDisease diagnostics with it’s highly sensitive LucentAD #pTau217 #bloodtest to aid in the early diagnosis of AD. #HealthAwareness

Bench to bedside, Quanterix and Lucent Diagnostics are committed to changing the landscape of AD. 🧠 💪 #AlzheimersDisease #pTau217 #Dementia #HealthAwareness #diagnostics #bloodtest #endALZ https://lnkd.in/ehYfkVGG

LucentAD p-Tau 217™, Lucent Diagnostics’ single blood biomarker test is the best market option for accurately aiding in the early diagnosis of #AlzheimersDisease. #pTau217 #Dementia #HealthAwareness #diagnostics #bloodtest #endALZ

Lucent Diagnostics, powered by Quanterix Simoa™ #technology, aims to change the landscape of #AlzheimersDisease diagnostics with it’s highly sensitive LucentAD #pTau217 #bloodtest to aid in the early diagnosis of AD. #HealthAwareness https://lnkd.in/g-9GZR8M